When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CERE - Cerevel Therapeutics: Parkinson's Could Be The Issue
Ceres Inc.
2024-03-06 07:20:44 ET
Summary
The FTC is requesting more information on the merger between Cerevel Therapeutics and AbbVie.
Concerns may be focused on the Phase 3 treatment Tavapadon for Parkinson's disease.
The market expects a 75% chance of the acquisition going through, which could be too low of an expectation considering some of the facts.
We'd pass, because the downside is high if anything were to go wrong, and there are unknowns here, but we see the value in this for some intrepid traders.